Cited by 666DNA Repair MechanismsPARP inhibition in cancer therapyFungal and yeast genetics research

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair

Sørensen, Claus Storgaard, Hansen, Lasse Tengbjerg, Dziegielewski, Jaroslaw, Syljuåsen, Randi G., Lundin, Cecilia, Bartek, Jiri, Helleday, Thomas·2005·Nature Cell Biology

DOI 10.1038/ncb1212

Open this paper in CoChat — free account

Abstract

The essential checkpoint kinase Chk1 is required for cell-cycle delays after DNA damage or blocked DNA replication. However, it is unclear whether Chk1 is involved in the repair of damaged DNA. Here we establish that Chk1 is a key regulator of genome maintenance by the homologous recombination repair (HRR) system. Abrogation of Chk1 function with small interfering RNA or chemical antagonists inhibits HRR, leading to persistent unrepaired DNA double-strand breaks (DSBs) and cell death after replication inhibition with hydroxyurea or DNA-damage caused by camptothecin. After hydroxyurea treatment, the essential recombination repair protein RAD51 is recruited to DNA repair foci performing a vital role in correct HRR. We demonstrate that Chk1 interacts with RAD51, and that RAD51 is phosphorylated on Thr 309 in a Chk1-dependent manner. Consistent with a functional interplay between Chk1 and RAD51, Chk1-depleted cells failed to form RAD51 nuclear foci after exposure to hydroxyurea, and cells expressing a phosphorylation-deficient mutant RAD51(T309A) were hypersensitive to hydroxyurea. These results highlight a crucial role for the Chk1 signalling pathway in protecting cells against lethal DNA lesions through regulation of HRR.

Integrity signals

Registry

Crossref · 10.1038/ncb1212

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Chk1 is an essential kinase that is regulated by Atr and required for the G 2 /M DNA damage checkpoint
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Sensing and repairing DNA double-strand breaks
Jackson, S. P. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.687 · Cited by 1,149
ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1
Zhao, H., & Piwnica-Worms, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4129-4139.2001 · Cited by 1,091
Untitled work
(1999) · PubMed · Cited by 1,030
Molecular views of recombination proteins and their control
West, S. C. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1127 · Cited by 977
ATR disruption leads to chromosomal fragmentation and early embryonic lethality
Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951
Rad51‐deficient vertebrate cells accumulate chromosomal breaks prior to cell death
Sonoda, E., Sasaki, M., Buerstedde, J., Bezzubova, O., Shinohara, A., Ogawa, H., Takata, M., Yamaguchi-Iwai, Y., & Takeda, S. (1998) · EMBO Journal · doi:10.1093/emboj/17.2.598 · Cited by 860
Targeted disruption of the Rad51 gene leads to lethality in embryonic mice.
Tsuzuki, T., Fujii, Y., Sakumi, K., Tominaga, Y., Nakao, K., Sekiguchi, M., Matsushiro, A., Yoshimura, Y., & MoritaT (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6236 · Cited by 792

Flagged first, then by citations

Show all 33 references

Sorted by citations

Items 201–300 of 662

ATR is required to complete meiotic recombination in mice
Pacheco, S., Maldonado-Linares, A., Marcet-Ortega, M., Rojas, C., Martínez-Marchal, A., Fuentes-Lazaro, J., Lange, J., Jasin, M., Keeney, S., Fernández-Capetillo, Ó., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04851-z · Cited by 60
The DNA-damage response: new molecular insights and new approaches to cancer therapy
Jackson, S. P. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370483 · Cited by 59
Dissecting the role of p53 phosphorylation in homologous recombination provides new clues for gain-of-function mutants
Restle, A., Färber, M., Baumann, C., Böhringer, M., Scheidtmann, K. H., Müller‐Tidow, C., & Wiesmüller, L. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn503 · Cited by 55
MEN1 Is a Melanoma Tumor Suppressor That Preserves Genomic Integrity by Stimulating Transcription of Genes That Promote Homologous Recombination-Directed DNA Repair
Fang, M., Xia, F., Mahalingam, M., Virbasius, C.-M. A., Wajapeyee, N., & Green, M. R. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00167-13 · Cited by 57
Activation of DNA damage signaling
Ljungman, M. E. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.02.014 · Cited by 54
Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response
Al-kaabi, M. M., Alshareeda, A. T., Jerjees, D. A., Muftah, A., Green, A. R., Alsubhi, N. H., Nolan, C. C., Chan, S. Y. T., Cornford, E. J., Madhusudan, S., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.576 · Cited by 53
Ataxin-3 promotes genome integrity by stabilizing Chk1
Tu, Y., Liu, H., Zhu, X., Shen, H., Ma, X., Wang, F., Huang, M., Gong, J., Li, X., Wang, Y., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx095 · Cited by 57
Activation of the S phase DNA damage checkpoint by mitomycin C
Mladenov, E., Tsaneva, I. R., & Anachkova, B. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20957 · Cited by 53
Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use
Abbotts, R., Dellomo, A. J., & Rassool, F. V. (2022) · Cancers · doi:10.3390/cancers14112640 · Cited by 54
Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways
Garcia, K., Blank, J. L., Bouck, D. C., Liu, X. J., Sappal, D. S., Hather, G., Cosmopoulos, K., Thomas, M. P., Kuranda, M., Pickard, M. D., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0634 · Cited by 52
The human intra-S checkpoint response to UVC-induced DNA damage
Kaufmann, W. K. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp230 · Cited by 56
EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases
Cousineau, I., & Belmaaza, A. (2011) · Molecular Genetics and Genomics · doi:10.1007/s00438-011-0612-5 · Cited by 57
MCL-1 Depletion Impairs DNA Double-Strand Break Repair and Reinitiation of Stalled DNA Replication Forks
Mattoo, A. R., PANDITA, R. K., Chakraborty, S., Charaka, V., Mujoo, K., Hunt, C. R., & Pandita, T. K. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00535-16 · Cited by 53
BET Inhibition Induces HEXIM1- and RAD51-Dependent Conflicts between Transcription and Replication
Bowry, A., Piberger, A. L., Rojas, P., Saponaro, M., & Petermann, E. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.079 · Cited by 51
Chk1-Dependent Regulation of Cdc25B Functions to Coordinate Mitotic Events
Löffler, H., Rebacz, B., Ho, A. D., Lukas, J., Bártek, J., & Krämer, A. (2006) · Cell Cycle · doi:10.4161/cc.5.21.3435 · Cited by 51
Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L
Nathansen, J., Lukiyanchuk, V., Hein, L., Stolte, M.-I., Borgmann, K., Löck, S., Kurth, I., Baumann, M. A., Krause, M., Linge, A., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01842-1 · Cited by 50
Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer Therapy
Andreassen, P. R., & Ren, K. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909787314011 · Cited by 50
Natural products targeting the ATR-CHK1 signaling pathway in cancer therapy
Ahmed, S., Alam, W., Aschner, M., Alsharif, K. F., Albrakati, A., Saso, L., & Khan, H. Z. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113797 · Cited by 51
G2-checkpoint targeting and radiosensitization of HPV/p16-positive HNSCC cells through the inhibition of Chk1 and Wee1
Busch, C., Kröger, M. S., Jensen, J., Kriegs, M., Gatzemeier, F., Petersen, C., Münscher, A., Rothkamm, K., & Rieckmann, T. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2016.11.017 · Cited by 49
Roles of Human AND-1 in Chromosome Transactions in S Phase
Yoshizawa-Sugata, N., & Masai, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806711200 · Cited by 49
5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repair
Srinivas, U. S., Dyczkowski, J., Beißbarth, T., Gaedcke, J., Mansour, W. Y., Borgmann, K., & Dobbelstein, M. (2015) · Oncotarget · doi:10.18632/oncotarget.3728 · Cited by 50
TopBP1 associates with NBS1 and is involved in homologous recombination repair
Morishima, K., Sakamoto, S., Kobayashi, J., Izumi, H., Suda, T., Matsumoto, Y., Tauchi, H., Ide, H., Komatsu, K., & Matsuura, S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.086 · Cited by 49
UbcH7 regulates 53BP1 stability and DSB repair
Han, X., Zhang, L., Chung, J., Pozo, F. M., Tran, A. P., Seachrist, D. D., Jacobberger, J. W., Keri, R. A., Gilmore, H. L., & Zhang, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408538111 · Cited by 48
A dual role of BRCA1 in two distinct homologous recombination mediated repair in response to replication arrest
Feng, Z., & Zhang, J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr748 · Cited by 50
Collaborative roles of γH2AX and the Rad51 paralog Xrcc3 in homologous recombinational repair
Sonoda, E., Zhao, G. Y., Kohzaki, M., Dhar, P. K., Kikuchi, K., Redon, C., Pilch, D. R., Bonner, W. M., Nakano, A., Watanabe, M., et al. (2007) · DNA Repair · doi:10.1016/j.dnarep.2006.10.025 · Cited by 47
Radiation-induced double-strand breaks require ATM but not Artemis for homologous recombination during S-phase
Köcher, S., Rieckmann, T., Rohaly, G., Mansour, W. Y., Dikomey, E., Dornreiter, I., & Dahm‐Daphi, J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks604 · Cited by 49
Disrupted mitochondrial homeostasis coupled with mitotic arrest generates antineoplastic oxidative stress
Hao, X., Bu, W., Lv, G., Xu, L., Hou, D., Wang, J., Liu, X., Yang, T., Zhang, X., Liu, Q., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02105-9 · Cited by 46
Collagen 1-mediated CXCL1 secretion in tumor cells activates fibroblasts to promote radioresistance of esophageal cancer
Yang, X., Chen, X., Zhang, S., Fan, W., Zhong, C., Liu, T., Cheng, G., ZHU, L. B., Liu, Q., Xi, Y., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113270 · Cited by 47
XPO1 inhibition synergizes with PARP1 inhibition in small cell lung cancer by targeting nuclear transport of FOXO3a
Wang, J., Sun, T., Meng, Z., Wang, L., Li, M., Chen, J., Qin, T., Yu, J., Zhang, M., Bie, Z., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.01.008 · Cited by 46
Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2
Pei, X., Dai, Y., Youssefian, L. E., Chen, S., Bodie, W. W., Takabatake, Y., Felthousen, J. G., Almenara, J. A., Kramer, L. B., Dent, P., et al. (2011) · Blood · doi:10.1182/blood-2011-02-339432 · Cited by 46
Preclinical Evaluation and Phase Ib Study of Prexasertib, a CHK1 Inhibitor, and Samotolisib (LY3023414), a Dual PI3K/mTOR Inhibitor
Hong, D. S., Moore, K. N., Bendell, J. C., Karp, D. D., Wang, J. S.-Z., Ulahannan, S. V., Jones, S. F., Wu, W., Donoho, G. P., Ding, Y. P., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3242 · Cited by 45
ATR protects ongoing and newly assembled DNA replication forks through distinct mechanisms
Leung, W., Simoneau, A., Saxena, S., Jackson, J., Patel, P. S., Limbu, M., Vindigni, A., & Zou, L. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112792 · Cited by 45
Mechanisms of ATR-mediated checkpoint signalling
Smits, V. A. J. (2010) · Frontiers in bioscience · doi:10.2741/3649 · Cited by 46
The extent of error-prone replication-restart by homologous recombination is controlled by Exo1 and checkpoint proteins
Tsang, E., Miyabe, I., Iraqui, I., Zheng, J., Lambert, S., & Carr, A. M. (2014) · Journal of Cell Science · doi:10.1242/jcs.152678 · Cited by 54
The true colors of autophagy in doxorubicin‑induced cardiotoxicity (Review)
Xiao, B., Hong, L., Cai, X., Mei, S., Ping, Z., & Shao, L. (2019) · Oncology Letters · doi:10.3892/ol.2019.10576 · Cited by 47
Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer
Baker, S. C., Mason, A. S., Slip, R. G., Skinner, K. T., Macdonald, A., Masood, O., Harris, R. S., Fenton, T. R., Periyasamy, M., Ali, S., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02235-8 · Cited by 45
Modelling the onset of senescence at the G1/S cell cycle checkpoint
Mombach, J. C., Bugs, C. A., & Chaouiya, C. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-s7-s7 · Cited by 50
Checkpoint kinase 1 is essential for normal B cell development and lymphomagenesis
Schuler, F., Weiss, J. G., Lindner, S. E., Lohmüller, M., Herzog, S., Spiegl, S. F., Menke, P., Geley, S., Labi, V., & Villunger, A. (2017) · Nature Communications · doi:10.1038/s41467-017-01850-4 · Cited by 44
Chk1 suppressed cell death
Meuth, M. (2010) · Cell Division · doi:10.1186/1747-1028-5-21 · Cited by 44
CHK1 levels correlate with sensitization to pemetrexed by CHK1 inhibitors in non-small cell lung cancer cells
Grabauskiene, S., Bergeron, E. J., Chen, G., Chang, A. C., Lin, J., Thomas, D. G., Giordano, T. J., Beer, D. G., Morgan, M. A., & Reddy, R. M. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.09.010 · Cited by 44
RhoB Promotes γH2AX Dephosphorylation and DNA Double-Strand Break Repair
Mamouni, K., Cristini, A., Guirouilh‐Barbat, J., Monferran, S., Lemarié, A., Faye, J., López, B. S., Favre, G., & Sordet, O. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01525-13 · Cited by 51
CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment
Klomp, J. E., Lee, Y. S., Goodwin, C. M., Papke, B., Klomp, J. A., Waters, A. M., Stalnecker, C. A., DeLiberty, J. M., Drizyte‐Miller, K., Yang, R. Y., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110060 · Cited by 44
The receptor tyrosine kinase inhibitor amuvatinib (MP470) sensitizes tumor cells to radio- and chemo-therapies in part by inhibiting homologous recombination
Zhao, H. W., Luoto, K. R., Meng, A. X., & Bristow, R. G. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.08.013 · Cited by 44
DNA-activated protein kinase functions in a newly observed S phase checkpoint that links histone mRNA abundance with DNA replication
Müller, B., Blackburn, J., Feijóo, C. G., Zhao, X., & Smythe, C. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200708106 · Cited by 44
Coupling Cellular Localization and Function of Checkpoint Kinase 1 (Chk1) in Checkpoints and Cell Viability
Wang, J., Han, X., Feng, X., Wang, Z., & Zhang, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.350397 · Cited by 42
The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment
Patties, I., Kallendrusch, S., Böhme, L., Kendzia, E., Oppermann, H., Gaunitz, F., Kortmann, R., & Glasow, A. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1434-2 · Cited by 42
Phosphorylation-dependent interactions of BLM and 53BP1 are required for their anti-recombinogenic roles during homologous recombination
Tripathi, V., Kaur, S., & Sengupta, S. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm238 · Cited by 44
ATF3 and Fra1 have opposite functions in JNK- and ERK-dependent DNA damage responses
Hamdi, M., Popeijus, H. E., Carlotti, F., Janssen, J. M., van der Burgt, C., Cornelissen‐Steijger, P., van de Water, B., Hoeben, R. C., Matsuo, K., & van Dam, H. (2008) · DNA repair · doi:10.1016/j.dnarep.2007.12.004 · Cited by 42
Chk1 Instability Is Coupled to Mitotic Cell Death of p53-deficient Cells in Response to Virus-induced DNA Damage Signaling
Jurvansuu, J., Fragkos, M., Ingemarsdotter, C. K., & Beard, P. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.06.077 · Cited by 42
Impact of DNA damage repair alterations on prostate cancer progression and metastasis
Lukashchuk, N., Barnicle, A., Adelman, C. A., Armenia, J., Kang, J., Barrett, J. C., & Harrington, E. A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1162644 · Cited by 43
Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein
Alshareeda, A. T., Negm, O. H., Aleskandarany, M. A., Green, A. R., Nolan, C. C., TigHhe, P. J., Madhusudan, S., Ellis, I. O., & Rakha, E. A. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3915-8 · Cited by 41
Vitamin D3 Ameliorates DNA Damage Caused by Developmental Exposure to Endocrine Disruptors in the Uterine Myometrial Stem Cells of Eker Rats
Elkafas, H., Ali, M. K., Morsy, E. M. E., Kamel, R., Thompson, W. E., Badary, O. A., Al-Hendy, A. A., & Yang, Q. (2020) · Cells · doi:10.3390/cells9061459 · Cited by 41
A Tale of Two Checkpoints: ATR Inhibition and PD-(L)1 Blockade
Ngoi, N. Y. L., Peng, G., & Yap, T. A. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-042320-025136 · Cited by 42
Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells
Zhao, J., Niu, X., Li, X., Edwards, H. J., Wang, G., Wang, Y., Taub, J. W., Lin, H., & Ge, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9185 · Cited by 40
CHK1 and RAD51 activation after DNA damage is regulated via urokinase receptor/TLR4 signaling
Narayanaswamy, P. B., Tkachuk, S., Haller, H. G., Dumler, I., & Kiyan, Y. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.291 · Cited by 40
ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias
Boudný, M., & Trbušek, M. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102026 · Cited by 41
PAK6 promotes homologous-recombination to enhance chemoresistance to oxaliplatin through ATR/CHK1 signaling in gastric cancer
Huang, W., Han, Z., Sun, Z., Feng, H., Zhao, L., Yuan, Q., Chen, C., Yu, S., Hu, Y., Yu, J., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05118-8 · Cited by 40
Hsp90 modulates CAG repeat instability in human cells
Mittelman, D., Sykoudis, K., Hersh, M. N., Lin, Y., & Wilson, J. H. (2010) · Cell Stress and Chaperones · doi:10.1007/s12192-010-0191-0 · Cited by 41
DNA repair and synthetic lethality
Guo, G., Zhang, F., Gao, R., Delsite, R., Feng, Z., & Powell, S. N. (2011) · International Journal of Oral Science · doi:10.4248/ijos11064 · Cited by 40
ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors
Smith, H. L., Willmore, E., Prendergast, L., & Curtin, N. J. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02745-0 · Cited by 42
Chk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibition
Höglund, A., Strömvall, K., Li, Y., Forshell, L. P., & Nilsson, J. A. (2011) · Cell Cycle · doi:10.4161/cc.10.20.17887 · Cited by 39
Will Targeting Chk1 Have a Role in the Future of Cancer Therapy?
Sakurikar, N., & Eastman, A. R. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.0767 · Cited by 39
ATM‐Dependent Recruitment of BRD7 is required for Transcriptional Repression and DNA Repair at DNA Breaks Flanking Transcriptional Active Regions
Hu, K., Li, Y., Wu, W., Xie, L., Yan, H., Cai, Y., Dong, C., Jiang, Q., Lin, L., Chen, Z. B., et al. (2020) · Advanced Science · doi:10.1002/advs.202000157 · Cited by 39
Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol ζ
Brondello, J., Pillaire, M., Rodriguez, C., Gourraud, P., Sèlves, J., Cazaux, C., & Piette, J. (2008) · Oncogene · doi:10.1038/onc.2008.212 · Cited by 42
Inhibition of ATR-Dependent Signaling by Protoapigenone and Its Derivative Sensitizes Cancer Cells to Interstrand Cross-link–Generating Agents In Vitro and In Vivo
Wang, H., Lee, A. Y., Chou, W., Wu, C., Tseng, C., Liu, K. Y.-T., Lin, W.-L., Chang, F., Chuang, D., Hunyadi, A., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0921 · Cited by 39
Function of TopBP1 in Genome Stability
Sokka, M., Parkkinen, S., Pospiech, H., & Syväoja, J. E. (2010) · Subcellular Biochemistry · doi:10.1007/978-90-481-3471-7_7 · Cited by 38
γH2AX, pChk1, and Wip1 as Potential Markers of Persistent DNA Damage Derived from Dibenzo[a,l]pyrene and PAH-Containing Extracts from Contaminated Soils
Niziolek, M., Dreij, K., Lundstedt, S., & Stenius, U. (2012) · Chemical Research in Toxicology · doi:10.1021/tx200436n · Cited by 39
Checkpoint-dependent and independent roles of the Werner syndrome protein in preserving genome integrity in response to mild replication stress
Basile, G., Leuzzi, G., Pichierri, P., & Franchitto, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1022 · Cited by 38
Rapamycin‐induced autophagy sensitizes A549 cells to radiation associated with DNA damage repair inhibition
Li, Y., Liu, F., Wang, Y., Li, D., Guo, F., Xu, L., Zeng, Z., Zhong, X., & Qian, K. (2016) · Thoracic Cancer · doi:10.1111/1759-7714.12332 · Cited by 38
TODRA, a lncRNA at the RAD51 Locus, Is Oppositely Regulated to RAD51, and Enhances RAD51-Dependent DSB (Double Strand Break) Repair
Gazy, I., Zeevi, D. A., Renbaum, P., Zeligson, S., Eini, L., Bashari, D., Smith, Y., Lahad, A., Goldberg, M., Ginsberg, D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134120 · Cited by 39
Apoptosis induced by replication inhibitors in Chk1-depleted cells is dependent upon the helicase cofactor Cdc45
Rodrı́guez, R., Gagou, M. E., & Meuth, M. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.4 · Cited by 38
Identification of DNA Repair Pathways That Affect the Survival of Ovarian Cancer Cells Treated with a Poly(ADP-Ribose) Polymerase Inhibitor in a Novel Drug Combination
Huehls, A. M., Wagner, J. M., Huntoon, C. J., & Karnitz, L. M. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080614 · Cited by 37
Multiparameter Lead Optimization to Give an Oral Checkpoint Kinase 1 (CHK1) Inhibitor Clinical Candidate: ( R )-5-((4-((Morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (CCT245737)
Osborne, J. D., Matthews, T. P., McHardy, T., Proisy, N., Cheung, K.-M. J., Lainchbury, M. D., Brown, N., Walton, M. I., Eve, P. D., Boxall, K. J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01938 · Cited by 37
Combination of Bifunctional Alkylating Agent and Arsenic Trioxide Synergistically Suppresses the Growth of Drug-Resistant Tumor Cells
Lee, P., Kakadiya, R., Su, T., & Lee, T. (2010) · Neoplasia · doi:10.1593/neo.10110 · Cited by 37
Akt1 inhibits homologous recombination in Brca1-deficient cells by blocking the Chk1-Rad51 pathway
Jia, Y., Song, W. M., Zhang, F., Yan, J., & Yang, Q. (2012) · Oncogene · doi:10.1038/onc.2012.211 · Cited by 37
High levels of RAD51 perturb DNA replication elongation and cause unscheduled origin firing due to impaired CHK1 activation
Parplys, A. C., Seelbach, J. I., Becker, S., Behr, M., Wrona, A., Jend, C., Mansour, W. Y., Joosse, S. A., Stuerzbecher, H.-W., Pospiech, H., et al. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1055996 · Cited by 36
Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells
Connell, C. M., Shibata, A., Tookman, L. A., Archibald, K. M., Flak, M. B., Pirlo, K. J., Lockley, M., Wheatley, S. P., & McNeish, I. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43976 · Cited by 36
MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells
Bridges, K. A., Chen, X., Liu, H., Rock, C. D., Buchholz, T. A., Shumway, S. D., Skinner, H. D., & Meyn, R. E. (2016) · Oncotarget · doi:10.18632/oncotarget.12311 · Cited by 36
The Replication Stress Response on a Narrow Path Between Genomic Instability and Inflammation
Técher, H., & Pasero, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.702584 · Cited by 37
The ATM regulated DNA damage response pathway as a chemo- and radiosensitisation target
Alao, J. P. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440902835475 · Cited by 36
Investigation of switch from ATM to ATR signaling at the sites of DNA damage induced by low and high LET radiation
Saha, J., Wang, M., & Cucinotta, F. A. (2013) · DNA repair · doi:10.1016/j.dnarep.2013.10.004 · Cited by 36
Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress
Zhang, Y., Lai, J., Du, Z., Gao, J., Yang, S., Gorityala, S., Xiong, X., Deng, O., Ma, Z., Yan, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9156 · Cited by 39
CDK12: a potential therapeutic target in cancer
Emadi, F., Teo, T., Rahaman, M. H., & Wang, S. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.035 · Cited by 36
Mus81-Eme1–dependent aberrant processing of DNA replication intermediates in mitosis impairs genome integrity
Calzetta, N. L., Besteiro, M. A. G., & Gottifredi, V. (2020) · Science Advances · doi:10.1126/sciadv.abc8257 · Cited by 35
Melatonin: A smart molecule in the DNA repair system
Mir, S. M., Aliarab, A., Goodarzi, G., Shirzad, M., Jafari, S. M., Qujeq, D., Tehrani, S. S., & Asadi, J. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3672 · Cited by 35
Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer
Xie, Y., Xiao, D., Li, D., Peng, M., Peng, W., Duan, H., & Yang, X. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1441222 · Cited by 35
Expression and regulation of RAD51 mediate cellular responses to chemotherapeutics
Yang, Z., Waldman, A. S., & Wyatt, M. D. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.022 · Cited by 34
MK-8776, a novel Chk1 inhibitor, exhibits an improved radiosensitizing effect compared to UCN-01 by exacerbating radiation-induced aberrant mitosis
Suzuki, M., Yamamori, T., Bo, T., Sakai, Y., & Inanami, O. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.04.002 · Cited by 35
S-Phase Cells Are More Sensitive to High-Linear Energy Transfer Radiation
Wang, H., Liu, S., Zhang, P., Zhang, S., Naidu, M. D., Wang, H., & Wang, Y. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.12.089 · Cited by 34
miR-21-mediated Radioresistance Occurs via Promoting Repair of DNA Double Strand Breaks
Hu, B., Wang, X., Hu, S., Ying, X., Wang, P., Zhang, X., Wang, J., Wang, H., & Wang, Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.772392 · Cited by 34
Retracted
SB225002 Promotes Mitotic Catastrophe in Chemo-Sensitive and -Resistant Ovarian Cancer Cells Independent of p53 Status In Vitro
Du, M., Qiu, Q., Gruslin, A., Gordon, J., He, M., Chan, C. C., Li, D., & Tsang, B. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054572 · Cited by 35
Amplifying tumour-specific replication lesions by DNA repair inhibitors – A new era in targeted cancer therapy
Helleday, T. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.044 · Cited by 34
Self-citation
Transcriptional profile of the homologous recombination machinery and characterization of the EhRAD51 recombinase in response to DNA damage in Entamoeba histolytica
López‐Casamichana, M., Orozco, E., Marchat, L. A., & López‐Camarillo, C. (2008) · BMC Molecular Biology · doi:10.1186/1471-2199-9-35 · Cited by 33
Genome Instability at Common Fragile Sites: Searching for the Cause of Their Instability
Franchitto, A. (2013) · BioMed Research International · doi:10.1155/2013/730714 · Cited by 34
Enhanced dependency of KRAS ‐mutant colorectal cancer cells on RAD 51‐dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae
Kalimutho, M., Bain, A. L., Mukherjee, B., Nag, P., Nanayakkara, D. M., Harten, S. K., Harris, J. L., Subramanian, G. N., Sinha, D., Shirasawa, S., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12040 · Cited by 32
Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1
Ahmed, A., Yang, J., Maya‐Mendoza, A., Jackson, D. A., & Ashcroft, M. A. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.42 · Cited by 31
The contribution of DNA replication stress marked by high-intensity, pan-nuclear γH2AX staining to chemosensitization by CHK1 and WEE1 inhibitors
Parsels, L. A., Parsels, J. D., Tanska, D. M., Maybaum, J., Lawrence, T. S., & Morgan, M. A. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1475827 · Cited by 31
New Phosphorylation Sites of Rad51 by c-Met Modulates Presynaptic Filament Stability
Chabot, T., Defontaine, A., Marquis, D., Renodon‐Cornière, A., Courtois, E., Fleury, F., & Chéraud, Y. (2019) · Cancers · doi:10.3390/cancers11030413 · Cited by 31
Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer
Meyer, F., Becker, S., Classen, S., Parplys, A. C., Mansour, W. Y., Riepen, B., Timm, S., Ruebe, C., Jasin, M., Wikman, H., et al. (2020) · Cells · doi:10.3390/cells9010238 · Cited by 31
Targeting the PI3K/mTOR Pathway Augments CHK1 Inhibitor–Induced Replication Stress and Antitumor Activity in High-Grade Serous Ovarian Cancer
Huang, T., Brill, E., Nair, J. R., Zhang, X., Wilson, K. M., Chen, L., Thomas, C. J., & Lee, J. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1439 · Cited by 32

Authors: Sørensen, C. S., Hansen, L. T., Dziegielewski, J., Syljuåsen, R. G., Lundin, C., Bartek, J., & Helleday, T.
Affiliations: Danish Cancer Society (DK)
University of Copenhagen (DK)
University of Sheffield (GB)
Stockholm University (SE)
Corresponding author: Helleday, Thomas
ORCID: Sørensen, Claus Storgaard
Syljuåsen, Randi G.
Lundin, Cecilia
Helleday, Thomas
Venue: Nature Cell Biology
Publisher: Springer Science and Business Media LLC
Published: 2005-01-23
Volume: 7
Issue: 2
Pages: 195-201
ISSN: 1465-7392 (ISSN-L)
1476-4679
DOI: 10.1038/ncb1212
OpenAlex: W2149795092
Cited by: 666
References: 33
Citations by year: 2026: 12 · 2025: 13 · 2024: 18 · 2023: 38 · 2022: 26 · 2021: 38 · 2020: 41 · 2019: 23 · 2018: 31 · 2017: 31 · 2016: 37 · 2015: 44 · 2014: 37 · 2013: 35 · 2012: 48
FWCI: 11.55
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Cell Biology (publishedVersion)
PubMed (publishedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Keywords: Chk1, homologous recombination repair, RAD51, DNA double-strand break repair, DNA damage response, cell cycle checkpoints, hydroxyurea, camptothecin, genome maintenance, replication inhibition
MeSH terms: Checkpoint Kinase 1, Animals, Camptothecin, DNA, DNA Damage, DNA Repair, DNA-Binding Proteins, Cricetinae, Humans, Hydroxyurea, Protein Kinases, Recombination, Genetic, Signal Transduction, Rad51 Recombinase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks